GENEX Trademark
Trademark Overview
On Tuesday, February 20, 2024, a trademark application was filed for GENEX with the United States Patent and Trademark Office. The USPTO has given the GENEX trademark a serial number of 98412216. The federal status of this trademark filing is EXAMINERS AMENDMENT - MAILED as of Wednesday, January 29, 2025. This trademark is owned by Genex, LLC. The GENEX trademark is filed in the Medical Instrument Products category with the following description:
Medical device, namely, transcranial magnetic stimulation apparatus, for treating individuals with intellectual and developmental disabilities, namely, Down syndrome, dyslexia, autism spectrum disorder, anxiety, depression, OCD, PTSD, ADHD and Dystonia; medical apparatus, namely, transcranial magnetic stimulation apparatus, for treating attention-deficit/hyperactivity disorder (ADHD), dyslexia, Down syndrome, dyslexia, autism spectrum disorder, anxiety, depression, OCD, PTSD, ADHD, and Dystonia; medical device, namely, transcranial magnetic stimulation apparatus, for treating Turner syndrome, cystic fibrosis, and Trisomy 13
General Information
| Serial Number | 98412216 |
| Word Mark | GENEX |
| Filing Date | Tuesday, February 20, 2024 |
| Status | 647 - EXAMINERS AMENDMENT - MAILED |
| Status Date | Wednesday, January 29, 2025 |
| Registration Number | 0000000 |
| Registration Date | NOT AVAILABLE |
| Mark Drawing | 3 - Illustration: Drawing or design which also includes word(s) / letter(s) / number(s) |
| Published for Opposition Date | NOT AVAILABLE |
Trademark Statements
| Description of Mark | The mark consists of a design of a DNA double helix above the stylized text "GENEX". |
| Indication of Colors claimed | Color is not claimed as a feature of the mark. |
| Goods and Services | Medical device, namely, transcranial magnetic stimulation apparatus, for treating individuals with intellectual and developmental disabilities, namely, Down syndrome, dyslexia, autism spectrum disorder, anxiety, depression, OCD, PTSD, ADHD and Dystonia; medical apparatus, namely, transcranial magnetic stimulation apparatus, for treating attention-deficit/hyperactivity disorder (ADHD), dyslexia, Down syndrome, dyslexia, autism spectrum disorder, anxiety, depression, OCD, PTSD, ADHD, and Dystonia; medical device, namely, transcranial magnetic stimulation apparatus, for treating Turner syndrome, cystic fibrosis, and Trisomy 13 |
Classification Information
| International Class | 010 - Surgical, medical, dental, and veterinary apparatus and instruments, artificial limbs, eyes, and teeth; orthopedic articles; suture materials. |
| US Class Codes | 026, 039, 044 |
| Class Status Code | 6 - Active |
| Class Status Date | Tuesday, February 20, 2024 |
| Primary Code | 010 |
| First Use Anywhere Date | NOT AVAILABLE |
| First Use In Commerce Date | NOT AVAILABLE |
Trademark Owner History
| Party Name | Genex, LLC |
| Party Type | 10 - Original Applicant |
| Legal Entity Type | 16 - Limited Liability Company |
| Address | Turlock, CA 95382 |
Trademark Events
| Event Date | Event Description |
| Tuesday, February 20, 2024 | NEW APPLICATION ENTERED |
| Tuesday, June 25, 2024 | NOTICE OF DESIGN SEARCH CODE E-MAILED |
| Tuesday, June 25, 2024 | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED |
| Tuesday, September 10, 2024 | ASSIGNED TO EXAMINER |
| Thursday, September 12, 2024 | NON-FINAL ACTION WRITTEN |
| Thursday, September 12, 2024 | NOTIFICATION OF NON-FINAL ACTION E-MAILED |
| Thursday, December 5, 2024 | CORRESPONDENCE RECEIVED IN LAW OFFICE |
| Thursday, December 5, 2024 | TEAS RESPONSE TO OFFICE ACTION RECEIVED |
| Friday, December 6, 2024 | TEAS/EMAIL CORRESPONDENCE ENTERED |
| Wednesday, January 29, 2025 | EXAMINER'S AMENDMENT ENTERED |
| Wednesday, January 29, 2025 | EXAMINERS AMENDMENT E-MAILED |
| Wednesday, January 29, 2025 | EXAMINERS AMENDMENT -WRITTEN |
| Wednesday, January 29, 2025 | NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED |
| Thursday, September 12, 2024 | NON-FINAL ACTION E-MAILED |
